Background: The use of antiplatelet therapy in combination with oral anticoagulants remains controversial. The objective of this study was to estimate and compare the incidence of adverse and coronary ...

Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients without a clear indication for ...

No consensus exists regarding the appropriate intensity of anticoagulation therapy in patients with mitral stenosis associated with atrial fibrillation (AF). In the National Study for Prevention of ...

Please provide your email address to receive an email when new articles are posted on . Direct oral anticoagulation in patients not previously indicated for it who underwent transcatheter aortic valve ...

SAN FRANCISCO, CA—Oral anticoagulation following transcatheter aortic valve replacement fails to lower the incidence of new subclinical cerebral lesions identified on imaging when compared with dual ...

Please provide your email address to receive an email when new articles are posted on . Patients were assigned oral anticoagulation alone (n = 344) or a combination of oral anticoagulation and ...

SAN DIEGO, CA—An attempt to clarify the best approach for antithrombotic therapy in patients with A-fib who are stable more than a year out from coronary stenting fell flat after slow enrollment led ...

Adding an anticoagulant to antiplatelet therapy for peripheral arterial disease (PAD) does little practical good while at the same time more than tripling the risk of dangerous bleeding, according to ...

Patients with newly diagnosed psoriatic arthritis have a higher risk of CVD. Resuming antithrombotic therapy with in patients with atrial fibrillation and a serious gastrointestinal bleed results in ...

This investigation was conducted at Kaiser Permanente Colorado (KPCO), a group-model, not-for-profit, health maintenance organization providing integrated medical care to approximately 435,000 members ...